NCT04561713View on ClinicalTrials.gov

Virtual Reality and Diagnostic of Attention Deficit Hyperactivity Disorder (ADHD) (PADA1)

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

July 21, 2020

Primary Completion Date

May 4, 2022

Study Completion Date

May 5, 2022

Conditions
Attention Deficit Hyperactivity Disorder
Interventions
PROCEDURE

Virtual reality task

Virtual reality application in an immersive room (CAVE) in three dimensions to assess child's sustained attention in a dynamic environment that is as close as possible to everyday situations.

Trial Locations (1)

33 076

CHU de Bordeaux, Bordeaux

All Listed Sponsors
lead

University Hospital, Bordeaux

OTHER

NCT04561713 - Virtual Reality and Diagnostic of Attention Deficit Hyperactivity Disorder (ADHD) (PADA1) | Biotech Hunter | Biotech Hunter